Results 161 to 170 of about 2,425,371 (368)

Midkine, a heparin-binding growth factor, and its roles in atherogenesis and inflammatory kidney diseases [PDF]

open access: bronze, 2016
Delia Lidia Șalaru   +5 more
openalex   +1 more source

Pharmacological aspects of kidney transplantation

open access: yes, 2020
Kidney transplantation is the treatment of choice in patients with end stage renal disease. Pharmacological management of medical co-morbidities. Successful clinical allotransplants only became possible with the development of effective methods of ...
Alkadi, Fatimah
core  

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

open access: yesArthritis Care &Research, EarlyView.
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh   +5 more
wiley   +1 more source

Effects of Causal Beliefs About Gout on Public Views About Gout Management: A Randomized Experimental Study

open access: yesArthritis Care &Research, EarlyView.
Objective Despite well‐described biologic causes, the public views unhealthy lifestyle choices as the primary cause of gout. This study investigated how causal beliefs about gout influence the public's views about its management. Methods In a randomized study, 201 members of the public viewed one of two 2‐minute videos about gout.
Rachel Murdoch   +6 more
wiley   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

open access: yesArthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel   +6 more
wiley   +1 more source

Black esophagus in the early kidney post-transplant period [PDF]

open access: hybrid, 2014
Fernando Caravaca‐Fontán   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy